Legend Biotech (LEGN) Debt to Equity (2019 - 2026)
Legend Biotech (LEGN) debt to equity from Mar 31, 2019 to Mar 31, 2026. The current Legend Biotech (LEGN) debt to equity is 40.23%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Legend Biotech (LEGN)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 41.28% | +22.53% |
| 2024 | 33.69% | +28.28% |
| 2023 | 26.26% | -31.29% |
| 2022 | 38.23% | +138.11% |
| 2021 | 16.05% | +2493.80% |
| 2020 | 0.62% | -112.45% |
| 2019 | -4.97% | -109.96% |
| 2018 | 49.94% | +2151.10% |
| 2017 | 2.22% | N/A |
Comparison Legend Biotech (LEGN) debt to equity with competitors
Legend Biotech (LEGN) debt to equity is 40.23%.